119 related articles for article (PubMed ID: 10590413)
1. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition.
Badalamente MA; Stracher A
Muscle Nerve; 2000 Jan; 23(1):106-11. PubMed ID: 10590413
[TBL] [Abstract][Full Text] [Related]
2. Leupeptin-based inhibitors do not improve the mdx phenotype.
Selsby J; Pendrak K; Zadel M; Tian Z; Pham J; Carver T; Acosta P; Barton E; Sweeney HL
Am J Physiol Regul Integr Comp Physiol; 2010 Nov; 299(5):R1192-201. PubMed ID: 20844259
[TBL] [Abstract][Full Text] [Related]
3. Effect of calpain and proteasome inhibition on Ca2+-dependent proteolysis and muscle histopathology in the mdx mouse.
Briguet A; Erb M; Courdier-Fruh I; Barzaghi P; Santos G; Herzner H; Lescop C; Siendt H; Henneboehle M; Weyermann P; Magyar JP; Dubach-Powell J; Metz G; Meier T
FASEB J; 2008 Dec; 22(12):4190-200. PubMed ID: 18728218
[TBL] [Abstract][Full Text] [Related]
4. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice.
Spencer MJ; Tidball JG
Exp Cell Res; 1996 Aug; 226(2):264-72. PubMed ID: 8806430
[TBL] [Abstract][Full Text] [Related]
5. In situ measurements of calpain activity in isolated muscle fibres from normal and dystrophin-lacking mdx mice.
Gailly P; De Backer F; Van Schoor M; Gillis JM
J Physiol; 2007 Aug; 582(Pt 3):1261-75. PubMed ID: 17510188
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of camostat mesilate on Duchenne muscular dystrophy in mdx mice.
Sawada H; Nagahiro K; Kikukawa Y; Ban S; Kakefuda R; Shiomi T; Yokosawa H
Biol Pharm Bull; 2003 Jul; 26(7):1025-7. PubMed ID: 12843632
[TBL] [Abstract][Full Text] [Related]
7. Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.
Shavlakadze T; White J; Hoh JF; Rosenthal N; Grounds MD
Mol Ther; 2004 Nov; 10(5):829-43. PubMed ID: 15509501
[TBL] [Abstract][Full Text] [Related]
8. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
[TBL] [Abstract][Full Text] [Related]
9. Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy.
Marques MJ; Ferretti R; Vomero VU; Minatel E; Neto HS
Muscle Nerve; 2007 Mar; 35(3):349-53. PubMed ID: 17143878
[TBL] [Abstract][Full Text] [Related]
10. Revertant fibers in the mdx murine model of Duchenne muscular dystrophy: an age- and muscle-related reappraisal.
Pigozzo SR; Da Re L; Romualdi C; Mazzara PG; Galletta E; Fletcher S; Wilton SD; Vitiello L
PLoS One; 2013; 8(8):e72147. PubMed ID: 24015212
[TBL] [Abstract][Full Text] [Related]
11. Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy.
Haddix SG; Lee YI; Kornegay JN; Thompson WJ
PLoS One; 2018; 13(10):e0205926. PubMed ID: 30379896
[TBL] [Abstract][Full Text] [Related]
12. Disodium cromoglycate protects dystrophin-deficient muscle fibers from leakiness.
Marques MJ; Ventura Machado R; Minatel E; Santo Neto H
Muscle Nerve; 2008 Jan; 37(1):61-7. PubMed ID: 17724738
[TBL] [Abstract][Full Text] [Related]
13. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
14. Heme Oxygenase-1 Influences Satellite Cells and Progression of Duchenne Muscular Dystrophy in Mice.
Pietraszek-Gremplewicz K; Kozakowska M; Bronisz-Budzynska I; Ciesla M; Mucha O; Podkalicka P; Madej M; Glowniak U; Szade K; Stepniewski J; Jez M; Andrysiak K; Bukowska-Strakova K; Kaminska A; Kostera-Pruszczyk A; Jozkowicz A; Loboda A; Dulak J
Antioxid Redox Signal; 2018 Jul; 29(2):128-148. PubMed ID: 29669436
[TBL] [Abstract][Full Text] [Related]
15. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
Montgomery E; Pennington C; Isales CM; Hamrick MW
Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):814-22. PubMed ID: 16078270
[TBL] [Abstract][Full Text] [Related]
16. Lifetime analysis of mdx skeletal muscle reveals a progressive pathology that leads to myofiber loss.
Massopust RT; Lee YI; Pritchard AL; Nguyen VM; McCreedy DA; Thompson WJ
Sci Rep; 2020 Oct; 10(1):17248. PubMed ID: 33057110
[TBL] [Abstract][Full Text] [Related]
17. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin.
Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ
J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of calpain and its endogenous inhibitor in the skeletal muscle of muscular dystrophy.
Kumamoto T; Ueyama H; Watanabe S; Yoshioka K; Miike T; Goll DE; Ando M; Tsuda T
Acta Neuropathol; 1995; 89(5):399-403. PubMed ID: 7618437
[TBL] [Abstract][Full Text] [Related]
19. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.
Grounds MD; Torrisi J
FASEB J; 2004 Apr; 18(6):676-82. PubMed ID: 15054089
[TBL] [Abstract][Full Text] [Related]
20. Amitriptyline is efficacious in ameliorating muscle inflammation and depressive symptoms in the mdx mouse model of Duchenne muscular dystrophy.
Manning J; Kulbida R; Rai P; Jensen L; Bouma J; Singh SP; O'Malley D; Yilmazer-Hanke D
Exp Physiol; 2014 Oct; 99(10):1370-86. PubMed ID: 24972834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
